| 1 |
32372943 | Glucocerebrosidase Defects as a Major Risk Factor for Parkinson's Disease. | 2020 |
1 |
| 2 |
31333408 | Lipids as Trans-Acting Effectors for α-Synuclein in the Pathogenesis of Parkinson's Disease. | 2019 |
1 |
| 3 |
29290548 | Reversible Conformational Conversion of α-Synuclein into Toxic Assemblies by Glucosylceramide. | 2018 Jan 3 |
4 |
| 4 |
29305919 | Pathological role of lipid interaction with α-synuclein in Parkinson's disease. | 2018 Oct |
4 |
| 5 |
29481565 | Analysis of age-related changes in psychosine metabolism in the human brain. | 2018 |
1 |
| 6 |
24903509 | Pathogenic role of ganglioside metabolism in neurodegenerative diseases. | 2014 Oct |
1 |
| 7 |
21396938 | Molecular basis for the glycosphingolipid-binding specificity of α-synuclein: key role of tyrosine 39 in membrane insertion. | 2011 May 13 |
2 |
| 8 |
21756873 | The fusogenic tilted peptide (67-78) of α-synuclein is a cholesterol binding domain. | 2011 Oct |
4 |
| 9 |
20114052 | Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides. | 2010 Mar 19 |
1 |